No Meningitis Outbreak in Ireland Linked to UK Cases, HSE Confirms

Despite a serious outbreak of meningococcal disease in the United Kingdom, health officials in Ireland have stated there is no evidence of an increase in invasive meningococcal disease activity within the country. The Health Service Executive (HSE) confirmed that all confirmed cases in Ireland to date are not linked to the outbreak currently being tackled by health authorities in Kent, UK.

Understanding Meningococcal Disease

Meningococcal disease is a bacterial infection that can lead to both meningitis and bloodstream infections. It is a rare, but serious infection, with sporadic cases occurring each year in Ireland. In the UK, the current outbreak in Kent has tragically resulted in the deaths of two young adults, with 15 laboratory-confirmed cases and a further 12 under investigation as of March 19, 2026. All confirmed cases in the UK outbreak have been among young adults.

HSE Surveillance and Response

Dr. John Cuddihy, the HSE’s National Director for Public Health, assured the public that there has been no rise in disease activity in Ireland beyond expected seasonal and background levels. The HSE’s national Public Health team is maintaining regular contact with the UK Health Security Agency to monitor the situation closely.

Recognizing the Symptoms

Health officials urge the public to be aware of the symptoms of meningococcal disease, which include:

• Fever
• Severe headache
• Vomiting
• Rapid breathing
• Cold hands and feet
• Drowsiness
• A rash that doesn’t fade under pressure

“Do not wait for a rash,” advises Dr. Cuddihy. “If someone is ill and getting worse, get medical aid immediately.”

Vaccination Information

Ireland’s national immunization program provides vaccines against several serotypes of the bacteria that cause meningococcal disease.

• MenB vaccine: Included in the free national childhood immunization schedule for babies born from October 1, 2016, administered at 2, 4 and 12 months.
• MenC vaccine: Offered to babies as part of the Primary Childhood Immunisation Programme.
• MenACWY vaccine: Offered in the first year of secondary school, protecting against types A, C, W, and Y. School immunization teams are currently administering this vaccine.

Parents are encouraged to return consent forms for the MenACWY vaccine sent home with their children in school.

Ongoing Monitoring and Public Health Advice

The HSE continues to emphasize routine surveillance and remains vigilant in monitoring for any changes in disease activity. The UK Health Security Agency has indicated that the situation is evolving and further cases are possible.